A Prospective Study of the Relationship among Asthma and COPD Phenotypes, Endotypes, and Genotypes for Personalized Medicine
Not Applicable
- Conditions
- Asthma COPD
- Registration Number
- JPRN-UMIN000016694
- Lead Sponsor
- aboratory of Clinical Pharmacogenomics, Shizuoka General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have received anticancer agents within the last 6 months Patients undergoing immunosuppressive therapy with steroids such as in diseases other than asthma or COPD Patients suffering from infection or patients with infection is suspected
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Exacerbation of asthma or COPD within one year
- Secondary Outcome Measures
Name Time Method symptom scores, lung function, fractional exhaled nitric oxide,